Clinical trials
2 active studies led by Cosmos Rx, Inc, of 2 in all
Source: ClinicalTrials.gov, Studies with Cosmos Rx, Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Cosmos Rx, Inc in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Cosmos Rx, Inc or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by Cosmos Rx, Inc, of 2 in all
Source: ClinicalTrials.gov, Studies with Cosmos Rx, Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Markets we cover where free public records show Cosmos Rx, Inc: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Cosmos Rx, Inc is in.
Stories on the topics Cosmos Rx, Inc works in.
Atrial fibrillation raises stroke risk about five-fold. Holter monitors, patches, implants and smartwatches…
Read
Patch pumps stick to the skin and deliver insulin without tubes. In August 2024, the FDA cleared the first…
Read
589 million adults live with diabetes, a number set to reach 853 million by 2050. Devices are changing how…
Read